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C. RESEARCH TRAINING PLANS 
Describe concisely the research and research training planned for the requested budget period, Including any course worit. 
13. APPLICANT SUMMARY OF ACTIVITIES 
A. CHANGES , 
There have not been any alterations in the focus of the research or the training plan 
of the student since the original proposal. 
B. PROGRESS REPORT 
During the past academic year at Georgia Tech I have been working diligently to 
complete both the synthesis of specific low molecular weight inhibitors of 
acetylcholinesterase as well as the curriculum of required courses set forth by Georgia 
Tech. I have satisfied the course requirements for matriculation by successfully completing 
courses in Advanced Physical Organic Chemistry, Macromolecular Structure, and 
Immunochemistry and I am a student in good standing. 
The research plan that I proposed called for the synthesis of derivatives which 
would improve the specificity, potency and hydrophobicity of compound 1 which has been 
previously synthesized by the Powers group. I have made significant progress towards 
completing the goals that I have set and I expect to fmalize the synthesis of several 
compounds for testing before the end of the summer quarter 1993. Compound 2 has been 
synthesized and shown to inhibit acetylcholinesterase in vitro. 
The frrst step in the synthesis of these analogs requires a 3-hydroxypicolinaldehyde 
(4) which can be synthesized by a variety of methods. I have made this compound several 
times by using a large excess of Mn~ and acetone at room temperature. The yields for 
this reaction are typically low with the highest yield being approximately 51%. This 
reaction has however proven to be unreliable at times because of the sensitivity to 
inactivation of the Mn(h catalyst I am interested in carrying out other literature procedures 
to synthesize this aldehyde that do not require Mn()z but proceed by rearrangement and 
hydrolysis of 3-hydroxypicolinaldehyde triacetate (3). This alternative should provide a 
better yield as well as improve the repeatability of the experiment 
Phenyl semicarbazide derivatives (6) have been synthesized by reacting the 
appropriately substituted phenyl isocyanate (S) with a 10 fold excess of hydrazine 
monohydrate in methylene chloride at zero degrees. The products are easily isolated by 
suction filtration. This method has produced several substituted phenylsemicarbazides 
which include: 2,6-d.ichloro, 4-chloro, 2,6-dimethyl, 2,6-difluro, 4-methoxy, 4-nitro, and 
3-nitro. The yields for these reactions are typically in the low eighties with the highest 
yield being 88% obtained from the 2,6 dimethyl derivative. 
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Starks, Kenneth M. 
The synthesis of pyridine semicarbazones (7) and hydrazides (compound 2 is an 
example of a hydrazide) have been canied out by reacting the appropriate 
phenylsemicarbazide or phenylhydrazide with the pyridine aldehyde in ethanol at reflux 
temperature for one hour. The clean·products are isolated by suction filtration. Yields for 
this reaction are generally 70-75%. The Schiff base analogs are then carbamylated by 
using pyridine and dimethylcarbamyl chloride at room temperature for 14 hours with 
subsequent methylation of the pyridinal nitrogen by methyl iodide then ion exchange by 
silver chloride. The carbamyl arion reaction yields up to 85% of its products while the yield 
for the salt ion exchange has not been determined. 
C. RESEARCH TRANING PLAN 
During the upcoming budget period I will be synthesizing more derivatives of 
compound 1 as potential acetylcholinesterase inhibitors. Iwill also be testing my 
compounds for their effectiveness by in vitro assays that have been worked out by the 
Power's group. All of the compounds that are deemed successful will be tested in animal 
models by a team of behavioral pharmacologists at The Medical College of Georgia. In the 
future we plan to submit the results of our joint investigations for publication. 
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B. Human subjects anct vttrtebrate animals (sH Instructions). 
15A. Ken received low grades in his courses in the fall quarter of 1992 and was placed on 
probation during the winter quarter of 1993. During the spring quarter of 1993, he received good 
grades in several courses and returned to normal graduate student status (good standing). He has 
decided to complete a Masters degree in chemistry before continuing with his graduate studies. 
He has now·completed all of the necessary course work and must simply complete enough 
research work for a Masters thesis. I expect Ken to complete sufficient research for a Masters 
thesis sometime during the next year. 
Ken's research progress to date has been satisfactory, but quite slow. He works 
consistently in the laboratory and is enthusiastic and interested in his research problem. He is 
very interested in the research field and is reading constantly in the area. However, he had taken 
a long time to learn synthesis skills and is still learning how to effectively perform techniques as 
simple as the recrystallization of reaction products. As he progresses, Ken is slowly making 
more of these skills part of his repertoire. He is beginning to work out the synthetic methods for 
the synthesis of the proposed acetylcholinesterase inhibitors (see progress report). He has now 
synthesized his first final inhibitor structure. Since he plans to synthesize a number of closely 
related derivatives to complete his thesis work, the remainder of the compounds should be more 
easily and quickly synthesized now that he has worked out the methods with the first derivative. 
15B. No human subjects or vertebrate animals are involved in this research. 
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14. The fellow was given a supplement of $295/month from a seed grant from the Georgia 
Tech/Medical College of GA seed grant program. The amount is the difference between the 
normal stipend of $13,000/year for chemistry graduate students and the amount provided by the 
Nlli fellowship. 
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pyridylmethylene)-4-(4-phenyl)diazinecarboxamide chloride (MHP 
133) is the parent for a new class of pyridinium salts which 
inhibit acetylcholinesterase (AChE) in vitro as well as in vivo. 
Fourteen new derivatives of MHP 133 have been synthesized with the 
intention of improving their hydrophobicity while maintaining 
their propensity to inhibit acetylcholinesterase. Upon prolonged 
incubation with AChE, the pyridinium salts exhibit progressive 
time-dependent inhibition according to first order kinetics with 
kobs/[I] values ranging from 3 to 345 M-ls-1. The enzyme didn't 
regain any activity after prolonged incubation with the inhibitors 
(1 day). The partition coefficients for each inhibitor were 
evaluated in octanol/water in order to determine their hydrophobic 
character as hydrophobicity is a key prerequisite for crossing the 
blood brain barrier. 
National Research Service Award to Kenneth M. Starks 
1'31 GM15612 
Patent Applications: 
Pyridinium Compounds, J. C. Powers, J. L. Buccafusco, K. L. 
Starks (1994) filed February 1994. 
Publications: 
Novel Pyridinium Derivatives as Inhibitors for 
Acetylcholinesterase, Starks, K. M., Ortega-Vilain, A.-C., 
Buccafusco, J. J., and Powers, J. C. (1995) J. Enzyme Inhibition, 
submitted. 
